Suppr超能文献

重症急性呼吸窘迫综合征中的肺血管阻塞:静脉内纤维蛋白溶解治疗后的血管造影改变

Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy.

作者信息

Greene R, Lind S, Jantsch H, Wilson R, Lynch K, Jones R, Carvalho A, Reid L, Waltman A C, Zapol W

出版信息

AJR Am J Roentgenol. 1987 Mar;148(3):501-8. doi: 10.2214/ajr.148.3.501.

Abstract

IV streptokinase was infused to test the potential reversibility of adult respiratory distress syndrome (ARDS) associated pulmonary vascular thrombosis in five patients suffering from severe ARDS with elevated mean pulmonary artery pressure, increased pulmonary vascular resistance, and angiographically documented pulmonary vascular thrombosis. At 48 hr there was clearance of obstructions in arteries larger than 1 mm in diameter in all patients, increased filling of the microvasculature and small arteries less than 1 mm in diameter in four patients, a fall in pulmonary vascular resistance in all patients, a rise in cardiac output in four patients, improved oxygenation (PAO2/FlO2) in three patients, and variable changes in shunt fraction and ventilator pressures. Expressed as a mean fraction of the preinfusion controls, the postinfusion physiologic values were pulmonary artery pressure = 0.89 mm Hg, pulmonary vascular resistance = 0.68 mm Hg X min/L, cardiac output = 1.36 L/min, central venous pressure = 0.77 cm H2O, pulmonary capillary wedge pressure = 0.92 mm Hg, PAO2/FlO2 = 1.08, and shunt fraction = 0.95. Follow-up angiography showed no evidence of reocclusion. Postmortem studies of the three nonsurvivors confirmed recanalization of thrombosed pulmonary arteries. One documented bleeding episode occurred. We conclude that fibrinolytic infusion can lyse thrombi and possibly improve hemodynamics and oxygenation in ARDS-associated pulmonary vascular thrombosis.

摘要

对五名患有严重成人呼吸窘迫综合征(ARDS)且平均肺动脉压升高、肺血管阻力增加以及血管造影证实存在肺血管血栓形成的患者,静脉输注链激酶以测试与ARDS相关的肺血管血栓形成的潜在可逆性。48小时时,所有患者直径大于1毫米的动脉阻塞均消失,四名患者直径小于1毫米的微血管和小动脉灌注增加,所有患者的肺血管阻力下降,四名患者的心输出量增加,三名患者的氧合(PAO2/FiO2)改善,分流分数和呼吸机压力有不同变化。以输注前对照的平均分数表示,输注后的生理值为肺动脉压 = 0.89毫米汞柱,肺血管阻力 = 0.68毫米汞柱×分钟/升,心输出量 = 1.36升/分钟,中心静脉压 = 0.77厘米水柱,肺毛细血管楔压 = 0.92毫米汞柱,PAO2/FiO2 = 1.08,分流分数 = 0.95。随访血管造影未显示再阻塞迹象。对三名非幸存者的尸检证实了血栓形成的肺动脉再通。发生了1例有记录的出血事件。我们得出结论,纤维蛋白溶解剂输注可溶解血栓,并可能改善ARDS相关肺血管血栓形成的血流动力学和氧合。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验